These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30462810)

  • 1. Congenital hyperinsulinism in two siblings with ABCC8 mutation: same genotype, different phenotypes.
    Sousa-Santos F; Simões H; Castro-Feijóo L; Rodríguez PC; Fernández-Marmiesse A; Fiaño RS; Rego T; Carracedo Á; Conde JB
    Arch Endocrinol Metab; 2018 Oct; 62(5):560-565. PubMed ID: 30462810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
    Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
    Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F
    Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
    Laimon W; Aboelenin HM; El Tantawi NT
    Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
    Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
    Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
    Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
    Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the ABCC8 gene mutation and phenotype in patients with congenital hyperinsulinism in western Saudi Arabia.
    Al-Agha AE; Ahmad IA
    Saudi Med J; 2013 Oct; 34(10):1002-6. PubMed ID: 24145932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked clinical heterogeneity in congenital hyperinsulinism due to a novel homozygous ABCC8 mutation.
    Takasawa K; Miyakawa Y; Saito Y; Adachi E; Shidei T; Sutani A; Gau M; Nakagawa R; Taki A; Kashimada K; Morio T
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):940-948. PubMed ID: 33595839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
    Üstün NU; Dilli D; Kundak AA; Okumus N; Erdoğan D; Apaydın S
    Fetal Pediatr Pathol; 2013 Dec; 32(6):412-7. PubMed ID: 23607867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.
    Gong C; Huang S; Su C; Qi Z; Liu F; Wu D; Cao B; Gu Y; Li W; Liang X; Liu M
    Pediatr Diabetes; 2016 May; 17(3):227-34. PubMed ID: 25639667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and phenotype-genotype review of 25 Omani children with congenital hyperinsulinism in infancy. A one-decade single-center experience.
    Al-Badi MK; Al-Azkawi HS; Al-Yahyaei MS; Mula-Abed WA; Al-Senani AM
    Saudi Med J; 2019 Jul; 40(7):669-674. PubMed ID: 31287126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
    Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.